FDA Application
-
NDC Search Results on Active Ingredient: Diclofenac
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| DICLOFENAC SODIUM | 49884-935-47 | Par Pharmaceutical Inc | NDA022122 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DICLOFENAC SODIUM | 50090-4246-0 | A-S Medication Solutions | NDA022122 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DICLOFENAC SODIUM | 68071-4382-1 | NuCare Pharmaceuticals,Inc. | NDA022122 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DICLOFENAC SODIUM | 21695-791-00 | Rebel Distributors Corp. | NDA022122 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC SODIUM | 63187-753-00 | Proficient Rx LP | NDA022122 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DICLOFENAC SODIUM | 63187-582-00 | Proficient Rx LP | NDA022122 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC SODIUM | 0067-8152-04 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
| DICLOFENAC SODIUM | 50436-3621-1 | Unit Dose Services | NDA022122 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC SODIUM | 0067-8152-09 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
| DICLOFENAC SODIUM | 68387-456-01 | Keltman Pharmaceuticals, Inc. | NDA022122 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC SODIUM | 0067-8152-01 | Haleon US Holdings LLC | NDA022122 | HUMAN OTC DRUG | NDA |
| DICLOFENAC POTASSIUM | 13913-011-01 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC POTASSIUM | 13913-012-03 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC POTASSIUM | 50192-113-01 | Nautilus Neurosciences, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC POTASSIUM | 13913-011-19 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC POTASSIUM | 13913-012-01 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC POTASSIUM | 69315-506-09 | Leading Pharma, LLC | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DICLOFENAC POTASSIUM | 13913-012-02 | Assertio Therapeutics, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC POTASSIUM | 50192-113-09 | Nautilus Neurosciences, Inc. | NDA022165 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC POTASSIUM | 13913-008-12 | Assertio Therapeutics, Inc. | NDA022202 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC POTASSIUM | 13913-008-11 | Assertio Therapeutics, Inc. | NDA022202 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC POTASSIUM | 69315-275-20 | Leading Pharma, LLC | NDA022202 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DICLOFENAC POTASSIUM | 13913-008-94 | Assertio Therapeutics, Inc. | NDA022202 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC | 42211-204-29 | Iroko Pharmaceuticals LLC | NDA204592 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC | 42211-204-23 | Iroko Pharmaceuticals LLC | NDA204592 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC | 42211-204-43 | Iroko Pharmaceuticals LLC | NDA204592 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC | 42211-203-29 | Iroko Pharmaceuticals LLC | NDA204592 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC | 42211-203-23 | Iroko Pharmaceuticals LLC | NDA204592 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC | 42211-203-43 | Iroko Pharmaceuticals LLC | NDA204592 | HUMAN PRESCRIPTION DRUG | NDA |
| DICLOFENAC SODIUM | 72189-498-04 | Direct_Rx | NDA204623 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
-
